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Abstract The tissue contents of total collagen and of 3-
hydroxypyridinium cross-links, pyridinoline (PYD) and deoxy-
pyridinoline (DPD), were measured in 15 samples of human 
aneurysms of Willis' Circle obtained at surgery and in 25 autopsy 
control samples of intracranial arteries of Willis' Circle obtained 
from 6 subjects who died of other causes than cerebral 
hemorrhage. PYD and DPD were detected fluorimetrically after 
HPLC separation. Total collagen content was significantly lower 
(/»< 0.001) in aneurysm samples (mean ± S.E.M. 2.50 ±0.33 
nmol of a 1(1) collagen chain per mg of delipidated and dried 
material) than in controls (mean ± S.E.M. 3.86 ±0.14). DPD, 
but not PYD, content appears to be lower in aneurysm walls. In 
the aneurysms, the tissue contents of PYD ranged from 212 to 
587 pmol/nmol of a 1(1) collagen chain (mean ± S.E.M. 
430 ±31) while in control samples the values observed ranged 
from 292 to 642 (mean ± S.E.M. 471 ± 21). The tissue content of 
DPD was measurable only in 6 aneurysm samples (60%), 
ranging from 12 to 60 pmol/nmol of a 1(1) collagen chain 
(mean ± S.E.M. 33 ± 9), while in control samples, DPD content 
ranged from 30 to 123 (mean ± S.E.M. 75 ± 5). 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The pathophysiological events related to the development 
of cerebral aneurysms are still poorly understood [1,2]. Ac-
cording to some theories, an inherited deficiency of collagen in 
cerebral arteries may be involved in the development of intra-
cranial aneurysms [3-5], while other authors suggest that 
aneurysms could result from an acquired degeneration of cer-
ebral arteries under the influence of arterial hypertension and 
atherosclerosis [6]. 
In fact, even if a deficiency of type III collagen was dem-
onstrated in both arteries and skin biopsies from patients with 
ruptured aneurysms [2,7], and a decrease of type III collagen 
synthesis has been supported by other authors [4,8,9], recent 
studies seem to exclude a congenital defect of collagen syn-
thesis in this pathology. Adamson et al. [6] showed that the 
frequencies of polymorphic variations in type III collagen 
gene loci were not different in affected individuals when com-
pared to control cases, providing no evidence for a genetic 
predisposition to cerebral aneurysms. Moreover, in some 
cases of multiple familial aneurysms a type III collagen defi-
ciency was not demonstrated [10], supporting the hypothesis 
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that cerebral aneurysms are related to a genetic defect only in 
a minority of cases. Finally, Kuvaniemi et al. [11] recently 
performed detailed analyses of coding sequences for type III 
collagen in 40 patients with intracranial aneurysms and in no 
case were significant mutations in the regulatory sequence of 
the gene observed. 
Recently, it was proposed that an alteration of the arterial 
wall matrix could play a significant role only in the formation 
of cerebral aneurysms, while other exogenous factors acting 
on the vessel wall seem to be involved in rupture of the aneur-
ysm [12]. The major component of the arterial wall is colla-
gen, particularly types I and III, which account for about 80-
90% of total collagen content [13] and are responsible for the 
mechanical properties of the vessel. The stability of type I and 
III collagen fibrils is mainly due to the presence of intra- and 
intermolecular cross-links; it is generally accepted that colla-
gen cross-linkage depends more on tissue localization than on 
the type of collagen, and that in tissues characterized by me-
chanical stress the cross-links formed via the hydroxylysine 
pathway, pyridinoline (PYD) and deoxypyridinoline (DPD), 
predominate. 
Mature extracellular type I and III collagen fibrils are sta-
bilized by covalent intermolecular cross-links formed by two 
main pathways, the allysine route, based on lysine aldehydes, 
and the hydroxyallysine route, based on hydroxylysine alde-
hydes. The hydroxylysine route predominates and leads to 
two non-reducible pyridinoline cross-links, PYD and DPD. 
PYD consists of three hydroxylysines, while DPD, the less 
abundant form, consists of two hydroxylysines and one lysine. 
In the hydroxylysine route, lysyl oxidase (protein lysine 6-
oxidase; EC 1.4.3.13) converts the amine side chains of spe-
cific hydroxylysine residues into the corresponding aldehyde 
hydroxyallysine [14], the two terminal regions of the collagen 
molecule being the only established sites of this reaction [15-
17]. 
Due to the above considerations, we decided to analyze 
both intracranial aneurysm walls and control samples from 
Willis' Circle in order to verify a possible difference in terms 
of total collagen and/or PYD and DPD contents. 
2. Materials and methods 
2.1. Tissue sampling 
Fifteen patients with a mean age of 49 years (ranging from 18 to 64) 
were studied. In no case were cerebral aneurysms found in members 
of the patients' families, nor were collagenopathies of genetic origin. 
In only three cases was it possible to operate the patients before the 
aneurysm ruptured. The locations of the aneurysms are reported in 
Table 1. All the aneurysms were saccular and were cut under the 
surgical microscope parallel to the clip, in order to analyze the entire 
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Table 1 
Content of tissue collagen (TCC) and pyridinolines (PYD and DPD) in 
CS ACA 
CS ACA 
CS ACA 
CS ACA 
CS ACA 
CS ACA 
CS ACoA 
CS ACoA 
CS ACoA 
CSICA 
CSICA 
CS ICA 
CS MCA 
CS MCA 
CS MCA 
CS MCA 
CS PCoA 
CS PCoA 
CS PCoA 
CS PcoA 
CS VBA 
CS VBA 
CS VBA 
CS VBA 
CS VBA 
ASa ACoA 
AS ACoA 
AS ACoA 
AS ACoA/MCA 
ASa ICA 
AS ICA 
AS ICA/PCoA 
AS MCA 
AS MCA 
AS MCA 
AS PCoA 
AS PCoA 
AS PCoA 
AS PCoA 
ASa PCoA 
TCC/dry tissue (nmol/mg) 
2.54 
4.85 
3.87 
4.87 
4.19 
4.45 
4.03 
3.26 
4.33 
3.30 
3.15 
3.49 
3.55 
3.58 
3.72 
5.51 
3.67 
4.51 
3.40 
3.99 
2.88 
5.06 
2.96 
3.70 
3.76 
0.99 
1.17 
2.35 
0.69 
1.89 
3.99 
3.51 
2.99 
3.64 
1.33 
1.04 
2.27 
3.89 
3.41 
4.41 
PYD/a 1(1) 
524 
351 
544 
436 
540 
530 
382 
574 
483 
525 
554 
571 
361 
431 
554 
387 
336 
292 
399 
470 
293 
359 
642 
594 
639 
353 
319 
332 
212 
544 
572 
270 
480 
589 
477 
310 
439 
481 
564 
504 
"Unrepaired aneurysm. 
sample and exclude variability related to collagen structure in different 
sections of the aneurysm sac. Aneurysm samples were immediately 
washed in saline solution, in order to remove clot residuals, frozen 
and kept at —80°C until processed. Informed consent, giving a 
lengthy list of specific problems concerning the surgical procedures, 
was signed by the patients (or responsible persons). 
Controls consisted of samples of human intracranial arteries of 
Willis' Circle obtained at autopsy from six subjects (mean age 60 
years, range 55-66) who had died of other causes than cerebral hem-
orrhage. In these cases informed consent was given by the patients' 
relatives. Autopsies were performed within 24 h of death, the cadavers 
being maintained at +4°C in order to minimize tissue degradation due 
to proteolysis. The control samples, obtained during autopsy per-
formed under proper magnification, were from internal carotid artery 
(ICA, n = 3), middle cerebral artery (MCA, n = 4), vertebro-basilar 
artery (VB, n - 5), anterior cerebral artery (ACA, n - 6), anterior com-
municating artery (ACoA, n = 3), and posterior communicating artery 
(PCoA, n-4). All samples were carefully washed out in saline and 
then frozen and kept at —80°C until analysis. 
2.2. Tissue analysis 
After thawing, the tissue was homogenized, delipidated with chloro-
form :methanol 2:1 (v/v) for 18 h at 4°C, washed with abundant 
distilled water, dried by vacuum centrifugation, and weighed. All 
the delipidated and dried material (ranging from 1.17 to 6.4 mg) 
was then hydrolysed in 5 ml of 6 N HC1 at 110°C for 18 h. 
The tissue content of collagen was expressed in terms of nmol of a 
1(1) collagen chain per mg of delipidated and dried material; the 
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control (CS) and aneurysm samples (AS) 
coll. chain (pmol/nmol) DPD/a 1(1) coll. chain (pmol/nmol) 
96 
53 
88 
51 
87 
87 
62 
93 
85 
93 
94 
100 
50 
70 
123 
51 
47 
30 
57 
56 
45 
51 
113 
105 
81 
< 6 
< 6 
23 
< 6 
< 6 
60 
19 
59 
12 
< 6 
< 6 
25 
< 6 
< 6 
< 6 
molarity of a 1(1) collagen chain was calculated on the basis of the 
hydroxyproline tissue content, expressed in nmol, assuming a ratio of 
hydroxyproline/a 1(1) chain approximately equal to 100 [18]. 
For hydroxyproline measurement [19], aliquots of the acid hydro-
lysate were dried by vacuum centrifugation and derivatized with di-
methylaminoazobenzene sulfonyl-chloride (DABS-C1). The derivati-
sate was injected (20 ul) into a Cig column and separation of the 
analyte was achieved in a gradient mode as previously described. 
The detection limit was 0.2 nmol/ml of acid hydrolysate and total 
inter-assay and intra-assay coefficients of variation (CV) were 6.3% 
and 9.3%, respectively. Hydroxyproline determination was performed 
in duplicate. 
The total amounts of PYD and DPD were measured according to 
the method of Black et al. [20] with some modifications [21] using 500 
|xl of hydrolysate. The detection limit, for both analytes, was 20 pmol/ 
ml of acid hydrolysate, corresponding to 6 pmol of analyte per nmol 
of a 1(1) collagen chain; total inter-assay and intra-assay CVs were 
10% and 13%, respectively. All analyses were performed in duplicate. 
The tissue contents of PYD and DPD were expressed in terms of 
pmol of analyte per nmol of a 1(1) collagen chain, in order to avoid 
the bias due to a possible difference of tissue content of collagen 
between samples. 
3. Results 
The chromatograms presented in Fig. 1, obtained from hy-
drolysate of a typical ICA control sample (A) and of two 
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Fig. 1. Examples of HPLC separation of PYD and DPD in control 
(A) and aneurysm samples (B, C). 
aneurysm samples (PCoA and MCA, B and C respectively), 
show the separation of PYD and DPD. It is noteworthy that 
in the chromatogram from one pathological sample (PCoA, 
B) the DPD peak was not detectable even when the peak area 
of PYD was comparable to that obtained by analyzing the 
hydrolysed ICA sample (A). This indicates that in some 
pathological samples DPD is undetectable under the used ex-
perimental conditions. 
Table 1 summarizes the results obtained by analyzing the 15 
aneurysm (AS) and the 25 control (CS) samples. The tissue 
collagen content (TCC), expressed in terms of nmol of a 1(1) 
collagen chain per mg of delipidated and dried material, 
ranged from 0.69 to 4.41 (mean ± S.E.M. 2.50 ±0.33) in the 
aneurysms, and from 2.54 to 5.51 (meaniS.E.M. 3.86±0.14) 
in the control samples; this indicates an average lower TCC 
(P< 0.001) in the pathological samples. 
The tissue content of DPD, but not of PYD, appears lower 
in aneurism samples than in control ones (Table 1). In partic-
ular, in the aneurysms PYD ranged from 212 to 587 pmol/ 
nmol of a 1(1) collagen chain (mean ± S.E.M. 430 ±31) while 
in control samples the values observed ranged from 292 to 642 
pmol/nmol of a 1(1) collagen chain (mean± S.E.M. 471 ±21), 
with no significant difference between the two groups. 
Remarkably, the tissue content of DPD was measurable in 
only six aneurysm samples (60%), ranging from 12 to 60 
pmol/nmol of a 1(1) collagen chain (meaniS.E.M. 33±9) 
while in nine samples the values did not reach the minimum 
detectable level of 6 pmol/nmol of a 1(1) collagen chain; in 
the 25 control samples, DPD content ranged from 30 to 123 
pmol/nmol of a 1(1) collagen chain (mean ± S.E.M. 75 ±5). 
Also on the less favorable arbitrary assumption of considering 
equal to 6 the DPD content in the nine aneurysms with an 
actual value < 6 pmol/nmol of a 1(1) collagen chain, it is 
possible to demonstrate the presence of a highly significant 
difference ( P < 0.001) in DPD content between the two 
groups. 
4. Discussion 
There are two major findings of this work: (a) the total 
collagen content is lower in aneurysm samples than in con-
trols ; (b) in aneurysm samples DPD (but not PYD) content is 
markedly lower than in control samples. The reduced amount 
of total collagen was not an unexpected result, since a de-
crease of type III collagen has already been reported to occur 
in cerebral aneurysm walls [2,4,7-9]. In contrast, the marked 
decrease of only DPD content represents a novel finding and 
an intriguing problem that deserves further experimental ef-
forts to be explained. In particular, it would be interesting to 
investigate the lysyl-hydroxylase activity in the aneurysm tis-
sue. The degree of lysyl-hydroxylation of procollagen chains 
could condition the availability of lysine residues and, there-
fore, the formation of DPD, which results from the conden-
sation of two hydroxylysines and one lysine. With reference to 
this point, it is worth remarking that variation of lysyl-hy-
droxylase activity is known to occur between different tissues 
[22], suggesting the existence of a control mechanism based on 
tissue-specific variations in enzyme activity [23]. 
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